Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR(®) study

BACKGROUND: Patients with prior invasive fungal infection (IFI) increasingly proceed to allogeneic hematopoietic cell transplantation (HSCT), however, little is known about the impact of prior IFI on survival. METHODS: Patients with pre-transplant IFI (cases; n=825) were compared to controls (n=10,2...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Bone Marrow Transplant
Hlavní autoři: Maziarz, Richard T., Brazauskas, Ruta, Chen, Min, McLeod, Aleksandra A., Martino, Rodrigo, Wingard, John R., Aljurf, Mahmoud, Battiwalla, Minoo, Dvorak, Christopher C., George, Biju, Guinan, Eva C., Hale, Gregory A., Lazarus, Hillard M., Lee, Jong-Wook, Liesveld, Jane L., Ramanathan, Muthalagu, Reddy, Vijay, Savani, Bipin N., Smith, Franklin O., Strasfeld, Lynne, Taplitz, Randy A., Ustun, Celalettin, Boeckh, Michael J., Gea-Banacloche, Juan, Lindemans, Caroline A., Auletta, Jeffery J., Riches, Marcie L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5358320/
https://ncbi.nlm.nih.gov/pubmed/27991895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2016.259
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky